Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

The trajectory of an infectious disease outbreak is affected by the behavior of individuals, and the behavior is often related to individuals' risk perception. We assessed temporal changes and geographical differences in risk perceptions and precautionary behaviors in response to H1N1 influenza.

Methods

1,290 US adults completed an online survey on risk perceptions, interests in pharmaceutical interventions (preventive intervention and curative intervention), and engagement in precautionary activities (information seeking activities and taking quarantine measures) in response to H1N1 influenza between April 28 and May 27 2009. Associations of risk perceptions and precautionary behaviors with respondents' sex, age, and household size were analyzed. Linear and quadratic time trends were assessed by regression analyses. Geographic differences in risk perception and precautionary behaviors were evaluated. Predictors of willingness to take pharmaceutical intervention were analyzed.

Results

Respondents from larger households reported stronger interest in taking medications and engaged in more precautionary activities, as would be normatively predicted. Perceived risk increased over time, whereas interest in pharmaceutical preventive interventions and the engagement in some precautionary activities decreased over time. Respondents who live in states with higher H1N1 incidence per population perceived a higher likelihood of influenza infection, but did not express greater interests in pharmaceutical interventions, nor did they engage in a higher degree of precautionary activities. Perceived likelihood of influenza infection, willingness to take medications and engagement in information seeking activities were higher for women than men.

Conclusions

Perceived risk of infection and precautionary behavior can be dynamic in time, and differ by demographic characteristics and geographical locations. These patterns will likely influence the effectiveness of disease control measures.
Appendix
Available only for authorised users
Literature
1.
go back to reference Halloran ME, Ferguson NM, Eubank S, Longini IM, Cummings DAT, Lewis B, Xu SF, Fraser C, Vullikanti A, Germann TC, et al: Modeling targeted layered containment of an influenza pandemic in the United States. Proceedings of the National Academy of Sciences of the United States of America. 2008, 105 (12): 4639-4644. 10.1073/pnas.0706849105.CrossRefPubMedPubMedCentral Halloran ME, Ferguson NM, Eubank S, Longini IM, Cummings DAT, Lewis B, Xu SF, Fraser C, Vullikanti A, Germann TC, et al: Modeling targeted layered containment of an influenza pandemic in the United States. Proceedings of the National Academy of Sciences of the United States of America. 2008, 105 (12): 4639-4644. 10.1073/pnas.0706849105.CrossRefPubMedPubMedCentral
2.
go back to reference Leung GM, Lam TH, Ho LM, Ho SY, Chan BH, Wong IO, Hedley AJ: The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong. J Epidemiol Community Health. 2003, 57 (11): 857-863. 10.1136/jech.57.11.857.CrossRefPubMedPubMedCentral Leung GM, Lam TH, Ho LM, Ho SY, Chan BH, Wong IO, Hedley AJ: The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong. J Epidemiol Community Health. 2003, 57 (11): 857-863. 10.1136/jech.57.11.857.CrossRefPubMedPubMedCentral
3.
go back to reference Brewer NT, Weinstein ND, Cuite CL, Herrington JE: Risk perceptions and their relation to risk behavior. Annals of Behavioral Medicine. 2004, 27 (2): 125-130. 10.1207/s15324796abm2702_7.CrossRefPubMed Brewer NT, Weinstein ND, Cuite CL, Herrington JE: Risk perceptions and their relation to risk behavior. Annals of Behavioral Medicine. 2004, 27 (2): 125-130. 10.1207/s15324796abm2702_7.CrossRefPubMed
4.
go back to reference Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND: Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 2007, 26 (2): 136-145. 10.1037/0278-6133.26.2.136.CrossRefPubMed Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND: Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 2007, 26 (2): 136-145. 10.1037/0278-6133.26.2.136.CrossRefPubMed
5.
go back to reference Brewer NT, Hallman WK: Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. Clin Infect Dis. 2006, 43 (11): 1379-1386. 10.1086/508466.CrossRefPubMed Brewer NT, Hallman WK: Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. Clin Infect Dis. 2006, 43 (11): 1379-1386. 10.1086/508466.CrossRefPubMed
6.
go back to reference Weinstein ND, Kwitel A, McCaul KD, Magnan RE, Gerrard M, Gibbons FX: Risk perceptions: Assessment and relationship to influenza vaccination. Health Psychology. 2007, 26 (2): 146-151. 10.1037/0278-6133.26.2.146.CrossRefPubMed Weinstein ND, Kwitel A, McCaul KD, Magnan RE, Gerrard M, Gibbons FX: Risk perceptions: Assessment and relationship to influenza vaccination. Health Psychology. 2007, 26 (2): 146-151. 10.1037/0278-6133.26.2.146.CrossRefPubMed
7.
go back to reference Weinstein ND: The Precaution Adoption Process. Health Psychology. 1988, 7 (4): 355-386. 10.1037/0278-6133.7.4.355.CrossRefPubMed Weinstein ND: The Precaution Adoption Process. Health Psychology. 1988, 7 (4): 355-386. 10.1037/0278-6133.7.4.355.CrossRefPubMed
8.
go back to reference Chapman GB, Coups EJ: Predictors of influenza vaccine acceptance among healthy adults. Preventive Medicine. 1999, 29 (4): 249-262. 10.1006/pmed.1999.0535.CrossRefPubMed Chapman GB, Coups EJ: Predictors of influenza vaccine acceptance among healthy adults. Preventive Medicine. 1999, 29 (4): 249-262. 10.1006/pmed.1999.0535.CrossRefPubMed
9.
go back to reference Ritvo P, Wilson K, Willms D, Upshur R, Grp CSS: Vaccines in the public eye. Nature Medicine. 2005, 11 (4): S20-S24. 10.1038/nm1220.CrossRefPubMed Ritvo P, Wilson K, Willms D, Upshur R, Grp CSS: Vaccines in the public eye. Nature Medicine. 2005, 11 (4): S20-S24. 10.1038/nm1220.CrossRefPubMed
10.
go back to reference Hershey JC, Asch DA, Thumasathit T, Meszaros J, Waters VV: The Roles of Altruism, Free Riding, and Bandwagoning in Vaccination Decisions. Organizational Behavior and Human Decision Processes. 1994, 59 (2): 177-187. 10.1006/obhd.1994.1055.CrossRef Hershey JC, Asch DA, Thumasathit T, Meszaros J, Waters VV: The Roles of Altruism, Free Riding, and Bandwagoning in Vaccination Decisions. Organizational Behavior and Human Decision Processes. 1994, 59 (2): 177-187. 10.1006/obhd.1994.1055.CrossRef
12.
go back to reference Wang TT, Palese P: Unraveling the mystery of swine influenza virus. Cell. 2009, 137 (6): 983-985. 10.1016/j.cell.2009.05.032.CrossRefPubMed Wang TT, Palese P: Unraveling the mystery of swine influenza virus. Cell. 2009, 137 (6): 983-985. 10.1016/j.cell.2009.05.032.CrossRefPubMed
13.
go back to reference Jones JH, Salathe M: Early assessment of anxiety and behavioral response to novel swine-origin influenza A(H1N1). PLoS One. 2009, 4 (12): e8032-10.1371/journal.pone.0008032.CrossRefPubMedPubMedCentral Jones JH, Salathe M: Early assessment of anxiety and behavioral response to novel swine-origin influenza A(H1N1). PLoS One. 2009, 4 (12): e8032-10.1371/journal.pone.0008032.CrossRefPubMedPubMedCentral
15.
go back to reference Chor JS, Ngai KL, Goggins WB, Wong MC, Wong SY, Lee N, Leung TF, Rainer TH, Griffiths S, Chan PK: Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. BMJ. 2009, 339: b3391-10.1136/bmj.b3391.CrossRefPubMedPubMedCentral Chor JS, Ngai KL, Goggins WB, Wong MC, Wong SY, Lee N, Leung TF, Rainer TH, Griffiths S, Chan PK: Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. BMJ. 2009, 339: b3391-10.1136/bmj.b3391.CrossRefPubMedPubMedCentral
16.
go back to reference Rubin GJ, Amlot R, Page L, Wessely S: Public perceptions, anxiety, and behaviour change in relation to the swine flu outbreak: cross sectional telephone survey. BMJ. 2009, 339: b2651-10.1136/bmj.b2651.CrossRefPubMedPubMedCentral Rubin GJ, Amlot R, Page L, Wessely S: Public perceptions, anxiety, and behaviour change in relation to the swine flu outbreak: cross sectional telephone survey. BMJ. 2009, 339: b2651-10.1136/bmj.b2651.CrossRefPubMedPubMedCentral
17.
go back to reference Goodwin R, Haque S, Neto F, Myers LB: Initial psychological responses to Influenza A, H1N1 ("Swine flu"). BMC Infect Dis. 2009, 9: 166-10.1186/1471-2334-9-166.CrossRefPubMedPubMedCentral Goodwin R, Haque S, Neto F, Myers LB: Initial psychological responses to Influenza A, H1N1 ("Swine flu"). BMC Infect Dis. 2009, 9: 166-10.1186/1471-2334-9-166.CrossRefPubMedPubMedCentral
18.
go back to reference Seale H, Heywood AE, McLaws ML, Ward KF, Lowbridge CP, Van D, MacIntyre CR: Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis. 2010, 10: 99-10.1186/1471-2334-10-99.CrossRefPubMedPubMedCentral Seale H, Heywood AE, McLaws ML, Ward KF, Lowbridge CP, Van D, MacIntyre CR: Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis. 2010, 10: 99-10.1186/1471-2334-10-99.CrossRefPubMedPubMedCentral
19.
go back to reference Lau JT, Griffiths S, Choi KC, Tsui HY: Avoidance behaviors and negative psychological responses in the general population in the initial stage of the H1N1 pandemic in Hong Kong. BMC Infect Dis. 2010, 10: 139-10.1186/1471-2334-10-139.CrossRefPubMedPubMedCentral Lau JT, Griffiths S, Choi KC, Tsui HY: Avoidance behaviors and negative psychological responses in the general population in the initial stage of the H1N1 pandemic in Hong Kong. BMC Infect Dis. 2010, 10: 139-10.1186/1471-2334-10-139.CrossRefPubMedPubMedCentral
20.
go back to reference Lau JT, Griffiths S, Choi KC, Lin C: Prevalence of preventive behaviors and associated factors during early phase of the H1N1 influenza epidemic. Am J Infect Control. 2010, 38 (5): 374-380. 10.1016/j.ajic.2010.03.002.CrossRefPubMed Lau JT, Griffiths S, Choi KC, Lin C: Prevalence of preventive behaviors and associated factors during early phase of the H1N1 influenza epidemic. Am J Infect Control. 2010, 38 (5): 374-380. 10.1016/j.ajic.2010.03.002.CrossRefPubMed
21.
go back to reference Setbon M, Raude J: Factors in vaccination intention against the pandemic influenza A/H1N1. The European Journal of Public Health. 2010, Setbon M, Raude J: Factors in vaccination intention against the pandemic influenza A/H1N1. The European Journal of Public Health. 2010,
22.
go back to reference Cheng C: To be paranoid is the standard? Panic resopnses to SARS outbreak in the Hong Kong special administrative region. Asian Perspective. 2004, 28 (1): 67-98. Cheng C: To be paranoid is the standard? Panic resopnses to SARS outbreak in the Hong Kong special administrative region. Asian Perspective. 2004, 28 (1): 67-98.
23.
go back to reference Smith MJ, Ellenberg SS, Bell LM, Rubin DM: Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States. Pediatrics. 2008, 121 (4): e836-843. 10.1542/peds.2007-1760.CrossRefPubMed Smith MJ, Ellenberg SS, Bell LM, Rubin DM: Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States. Pediatrics. 2008, 121 (4): e836-843. 10.1542/peds.2007-1760.CrossRefPubMed
24.
go back to reference Hochman M, Hochman S, Bor D, McCormick D: News media coverage of medication research: reporting pharmaceutical company funding and use of generic medication names. JAMA. 2008, 300 (13): 1544-1550. 10.1001/jama.300.13.1544.CrossRefPubMed Hochman M, Hochman S, Bor D, McCormick D: News media coverage of medication research: reporting pharmaceutical company funding and use of generic medication names. JAMA. 2008, 300 (13): 1544-1550. 10.1001/jama.300.13.1544.CrossRefPubMed
25.
go back to reference Gustafson PE: Gender differences in risk perception: Theoretical and methodological perspectives. Risk Analysis. 1998, 18 (6): 805-811. 10.1023/B:RIAN.0000005926.03250.c0.CrossRefPubMed Gustafson PE: Gender differences in risk perception: Theoretical and methodological perspectives. Risk Analysis. 1998, 18 (6): 805-811. 10.1023/B:RIAN.0000005926.03250.c0.CrossRefPubMed
26.
go back to reference Bish A, Michie S: Demographic and attitudinal determinants of protective behaviours during a pandemic: A review. Br J Health Psychol. 2010, Bish A, Michie S: Demographic and attitudinal determinants of protective behaviours during a pandemic: A review. Br J Health Psychol. 2010,
27.
go back to reference Fox JP, Hall CE, Cooney MK, Foy HM: Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol. 1982, 116 (2): 212-227.PubMed Fox JP, Hall CE, Cooney MK, Foy HM: Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol. 1982, 116 (2): 212-227.PubMed
28.
go back to reference Galvani AP, Medlock J, Chapman GB: The ethics of influenza vaccination. Science. 2006, 313 (5788): 758-760. author reply 758-760PubMed Galvani AP, Medlock J, Chapman GB: The ethics of influenza vaccination. Science. 2006, 313 (5788): 758-760. author reply 758-760PubMed
29.
go back to reference Longini IM, Koopman JS, Monto AS, Fox JP: Estimating household and community transmission parameters for influenza. Am J Epidemiol. 1982, 115 (5): 736-751.PubMed Longini IM, Koopman JS, Monto AS, Fox JP: Estimating household and community transmission parameters for influenza. Am J Epidemiol. 1982, 115 (5): 736-751.PubMed
30.
go back to reference Medlock J, Galvani AP: Optimizing influenza vaccine distribution. Science. 2009, 325 (5948): 1705-1708. 10.1126/science.1175570.CrossRefPubMed Medlock J, Galvani AP: Optimizing influenza vaccine distribution. Science. 2009, 325 (5948): 1705-1708. 10.1126/science.1175570.CrossRefPubMed
31.
go back to reference Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N, Cavalieri ML, Guglielmo MC, Areso MS, Gilligan T, et al: Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med. 2010, 362 (1): 45-55. 10.1056/NEJMoa0907673.CrossRefPubMed Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N, Cavalieri ML, Guglielmo MC, Areso MS, Gilligan T, et al: Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med. 2010, 362 (1): 45-55. 10.1056/NEJMoa0907673.CrossRefPubMed
32.
go back to reference Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, et al: Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009, 302 (17): 1896-1902. 10.1001/jama.2009.1583.CrossRefPubMed Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, et al: Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009, 302 (17): 1896-1902. 10.1001/jama.2009.1583.CrossRefPubMed
33.
go back to reference Loewenstein G, Mather J: Dynamic Processes in Risk Perception. Journal of Risk and Uncertainty. 1990, 3 (2): 155-175. 10.1007/BF00056370.CrossRef Loewenstein G, Mather J: Dynamic Processes in Risk Perception. Journal of Risk and Uncertainty. 1990, 3 (2): 155-175. 10.1007/BF00056370.CrossRef
35.
go back to reference Khazeni N, Hutton DW, Garber AM, Owens DK: Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med. 2009, 151 (12): 840-853.CrossRefPubMedPubMedCentral Khazeni N, Hutton DW, Garber AM, Owens DK: Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med. 2009, 151 (12): 840-853.CrossRefPubMedPubMedCentral
36.
go back to reference Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK: Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med. 2009, 151 (12): 829-839.CrossRefPubMedPubMedCentral Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK: Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med. 2009, 151 (12): 829-839.CrossRefPubMedPubMedCentral
37.
go back to reference Duncan B: How the media reported the first days of the pandemic (H1N1) 2009: results of EU-wide media analysis. Euro Surveill. 2009, 14 (30): 19286-PubMed Duncan B: How the media reported the first days of the pandemic (H1N1) 2009: results of EU-wide media analysis. Euro Surveill. 2009, 14 (30): 19286-PubMed
38.
go back to reference Sax LJ, Gilmartin SK, Bryant AN: Assessing response rates and nonresponse bias in web and paper surveys. Research in Higher Education. 2003, 44 (4): 409-432. 10.1023/A:1024232915870.CrossRef Sax LJ, Gilmartin SK, Bryant AN: Assessing response rates and nonresponse bias in web and paper surveys. Research in Higher Education. 2003, 44 (4): 409-432. 10.1023/A:1024232915870.CrossRef
Metadata
Title
The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza
Publication date
01-12-2010
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-296

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.